Biotech

All Articles

Metsera partner with Amneal to lock down GLP-1 source

.With very early stage 1 information right now out in the wild, metabolic condition clothing Metsera...

Rivus blog posts records to support muscle-sparing excessive weight medication cases

.Rivus Pharmaceuticals has actually unveiled the records responsible for its stage 2 weight problems...

BMS pays $110M to form T-cell therapy deal, assisting Main get opportunity to improve prioritized pipeline

.Bristol Myers Squibb is actually paying Prime Medication $110 million in advance to build reagents ...

Generate increases an additional $1B-plus Huge Pharma partnership

.Novartis has printer inked an offer possibly worth greater than $1 billion along with Flagship-foun...

Metsera GLP-1 data cut exposes 7.5% weight loss at 36 times

.Recently debuted Metsera is actually unfolding some stage 1 data for its own GLP-1 receptor agonist...

Flagship hopes biotechs group to Mirai to improve hereditary meds

.Amid the hereditary medicines branches ethnicity, Crown jewel Pioneering is actually introducing a ...

BioAge eyes $180M coming from IPO, exclusive positioning for being overweight trials

.BioAge Labs is looking at around $180 million in initial profits coming from an IPO and a personal ...

Merck's LAG-3 combo stops working colon cancer period 3 research study

.An attempt by Merck &amp Co. to open the microsatellite stable (MSS) metastatic colorectal cancer m...

Spanish VC finalizes $200M life scientific researches fund

.Spain-based Asabys Allies has actually shut a fund of 180 million europeans ($ 200 million), funds ...

BioAge brings in $198M coming from IPO as obesity biotech joins Nasdaq

.BioAge Labs is introducing practically $200 thousand by means of its own Nasdaq IPO today, with the...